Application of equol in inhibiting phytopathogen

By using equol to prepare plant disease inhibitors or agricultural fungicides, the resistance and environmental problems caused by the reliance on chemical pesticides for the control of oomycetes in existing technologies have been solved, achieving specific inhibition and green control effects against oomycetes.

CN118947703AActive Publication Date: 2024-11-15TOBACCO RESEARCH INSTITUTE OF CHINESE ACADEMY OF AGRICULTURAL SCIENCES (QINGZHOU TOBACCO RESEARCH INSTITUTE OF CHINA NATIONAL TOBACCO COMPANY) +1

Patent Information

Application Number
CN202411043544.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-15
Estimated Expiration
2044-07-31

AI Technical Summary

Technical Problem

Existing methods for controlling oomycetes mainly rely on chemical pesticides, which leads to pathogen resistance and environmental problems, and lacks green and environmentally friendly control methods.

Method used

Using equol as a bacteriostatic agent, plant disease inhibitors or agricultural fungicides are prepared to inhibit the growth of plant pathogenic oomycetes and sporangium formation, thereby preventing and controlling plant diseases.

Benefits of technology

Estrol has specific inhibitory activity against pathogenic oomycetes, is environmentally friendly, and provides a new approach to green fungicides, effectively preventing and controlling plant diseases.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118947703A_ABST
    Figure CN118947703A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of prevention and control of plant pathogens, and particularly relates to application of equol in inhibition of plant pathogens. Specifically, the antibacterial activity of the equol on common plant pathogenic fungi and oomycetes is evaluated by adopting an in-vitro culture mode, and researches find that the equol has specific inhibitory activity on the oomycetes and has an obvious inhibitory effect on growth of the pathogenic oomycetes, formation of pathogenic oomycete sporangium and generation of zoospore; the environment-friendly medicine equol provides a new thought for prevention and treatment of pathogenic oomycetes, provides a better scientific basis for research and development of a pathogenic oomycete green bactericide, and has good practical application value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of plant pathogen prevention and control, and particularly relates to application of equol in inhibiting plant pathogens. Background Art

[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.

[0003] Oomycetes are filamentous eukaryotic microorganisms and an important class of pathogenic organisms that are ubiquitous in nature. They are named after the oospores they produce. Oomycetes are eukaryotic organisms but not fungi. Their chromosome multiples, cell walls, cell membranes, mitochondria, mycelial structures, and asexual spore morphology are significantly different from those of fungi. Most known oomycete species are the culprits of plant diseases, including Phytophthora, Downy Mildew, and Pythium, which pose a huge threat to food and vegetable production.

[0004] Phytophthora is a pathogenic fungus that can infect a variety of plants. It causes serious damage to young organs or tissues of plants, such as newly sprouted buds, the base of seedling stems, developing fruits, young stems and leaves, and floral organs. If the base of the stem is infected, the stems, leaves, and fruits above it will show varying degrees of wilt, and in severe cases, the plant will fall over and die. Phytophthora likes to overwinter in the soil with diseased remains, so the diseases it causes are often dry soil-borne diseases.

[0005] Pythium is a highly adaptable fungus that attacks leaves, flowers, fruits, etc. The wilt caused by it is not limited to high temperature seasons. Even if the temperature is low, as long as the high humidity weather continues, the disease may occur seriously in May or September.

[0006] Existing pathogenic oomycetes control methods mainly rely on chemical pesticides, such as metalaxyl, azoxystrobin, and benzylpropionamide. Long-term use not only makes pathogens resistant, but also brings serious environmental problems. Therefore, the development of green and environmentally friendly pathogenic oomycetes control methods is an important demand for promoting agricultural development.

[0007] Equol (Eq) is an isoflavone diol produced by the metabolism of soybean isoflavones (SI) through intestinal flora. It is the most potent antioxidant among soybean isoflavones and their metabolites, and has multiple biological activities, such as antioxidant, anti-inflammatory, and anti-tumor. However, its application in the prevention and treatment of plant diseases, especially those mediated by pathogenic oomycetes, has rarely been reported. Summary of the invention

[0008] In view of the deficiencies in the above-mentioned prior art, the inventors, after long-term technical and practical exploration, provide the application of equol in inhibiting plant pathogens. Specifically, the present invention has found through research that equol has specific inhibitory activity against oomycetes. Based on the above research results, the present invention is completed.

[0009] In order to achieve the above technical objectives, the present invention adopts the following technical solutions:

[0010] The first aspect of the present invention provides the use of equol in any one or more of the following:

[0011] (a) inhibiting plant pathogens or preparing plant pathogen inhibitors;

[0012] (b) Suppressing plant diseases or preparing plant disease suppressants.

[0013] The equol may be a pure product, a solvent compound or an isomer (such as R-equol or S-equol).

[0014] The second aspect of the present invention provides an agricultural fungicide composition, which at least comprises equol and an adjuvant.

[0015] In the present invention, the agricultural fungicide composition can be used as a plant pesticide or a plant fertilizer or a component thereof, and thus applied to plants to prevent and control the occurrence of plant diseases mediated by the above-mentioned plant pathogens.

[0016] Therefore, the third aspect of the present invention provides a method for controlling plant diseases, which comprises applying the above-mentioned equol or the above-mentioned agricultural fungicide composition to plants.

[0017] Compared with the existing technical solutions, the above one or more technical solutions have the following beneficial effects:

[0018] The above technical scheme adopted an in vitro culture method to evaluate its antibacterial activity against common plant pathogenic fungi and oomycetes. The study found that equol has specific inhibitory activity against oomycetes. Equol has obvious inhibitory effects on the growth of pathogenic oomycetes, the formation of pathogenic oomycete sporangia and the production of zoospores. Equol, an environmentally friendly drug, provides a new idea for the prevention and control of pathogenic oomycetes, provides a better scientific basis for the research and development of green fungicides for pathogenic oomycetes, and has good practical application value. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.

[0020] Figure 1The effect of R- / S-Eq on the activity of 10 plant pathogens in the examples of the present invention;

[0021] Figure 2 The effect of different concentrations of R- / S-Eq on the mycelial growth of tobacco phytophthora in the examples of the present invention;

[0022] Figure 3 The effects of R-Eq on the formation of sporangia and zoospore germination of tobacco Phytophthora in the examples of the present invention; wherein A is the germination of tobacco Phytophthora sporangia induced by treating mycelium with R-Eq at different concentrations; and B is the germination of spores on the drug-containing plates with different concentrations of R-Eq.

[0023] Figure 4 : This is the biological toxicity effect of R / S-Eq on zebrafish in the embodiment of the present invention. In the figure, the common logarithm of the concentration is used as the horizontal axis, that is, the logarithm with base 10; the mortality rate is used as the vertical axis. DETAILED DESCRIPTION

[0024] It should be noted that the following detailed descriptions are illustrative and are intended to provide further explanation of the present application. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present application belongs.

[0025] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit the exemplary embodiments according to the present application. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprise" and / or "include" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.

[0026] In a typical embodiment of the present invention, the use of equol in any one or more of the following is provided:

[0027] (a) inhibiting plant pathogens or preparing plant pathogen inhibitors;

[0028] (b) Suppressing plant diseases or preparing plant disease suppressants.

[0029] The equol may be a pure product, a solvent compound or an isomer (such as R-equol or S-equol).

[0030] In the above (a), the plant pathogenic bacteria include plant pathogenic fungi and plant pathogenic oomycetes, preferably plant pathogenic oomycetes. The present invention has found through research that equol has specific inhibitory activity against plant pathogenic oomycetes, and has a significant inhibitory effect on the growth of pathogenic oomycetes, the formation of pathogenic oomycete sporangia and the production of zoospores.

[0031] Among them, the plant pathogenic fungi include Fusarium equisetifolia, Fusarium oxysporum, Fusarium solani and Alternaria alternata, and the plant pathogenic oomycetes include Pythium ultimum, Phytophthora nicotianae, Phytophthora sojae, Phytophthora capsici, Pythium aphanidermatum and Pythium solani.

[0032] In (b), the plant diseases are plant diseases mediated by the plant pathogens in (a), such as plant black shank disease, phytophthora blight, wilt, root rot, brown star disease, etc., which are not specifically limited here.

[0033] The dosage form of the plant pathogen inhibitor or plant disease inhibitor can be powder (wettable powder), granule, water dispersible granule, emulsifiable concentrate, microemulsion or aqueous solution, etc., which is not specifically limited here.

[0034] The plant pathogen inhibitor or plant disease inhibitor also includes an auxiliary material acceptable in the agricultural field, and the auxiliary material includes one or more of a dispersant, a wetting agent, a disintegrant, a binder, a defoamer, an antifreeze agent, a thickener, a filler and a solvent. The present invention has no special restrictions on the source of the auxiliary material, and generally commercially available products can be used.

[0035] In the present invention, the host plants of the plant pathogens include trees, fruit trees, vegetables, food crops, cash crops, etc., and further include soybeans, corn, wheat, peppers, cotton, tomatoes, beets, sweet potatoes, tobacco, eggplants, strawberries, apples, citrus, chrysanthemums, dahlias, pumpkins, watermelons, bananas, salvia miltiorrhiza, etc., without specific limitation herein.

[0036] In another specific embodiment of the present invention, an agricultural fungicide composition is provided, which at least comprises equol and an adjuvant.

[0037] The equol may be a pure product, a solvent compound or an isomer (such as R-equol or S-equol).

[0038] The auxiliary materials include one or more of dispersants, wetting agents, disintegrants, binders, defoamers, antifreeze agents, thickeners, fillers and solvents. The present invention has no special restrictions on the sources of the auxiliary materials, and generally commercial products can be used.

[0039] In the present invention, the agricultural fungicide composition can be used as a plant pesticide or a plant fertilizer or a component thereof, and thus applied to plants to prevent and control the occurrence of plant diseases mediated by the above-mentioned plant pathogens.

[0040] Therefore, in another specific embodiment of the present invention, a method for preventing and controlling plant diseases is provided, the method comprising applying the above-mentioned equol or the above-mentioned agricultural fungicide composition to the plant.

[0041] The plants include trees, fruit trees, vegetables, food crops and cash crops, and further include soybeans, corn, wheat, peppers, cotton, tomatoes, beets, sweet potatoes, tobacco, eggplants, strawberries, apples, citrus, chrysanthemums, dahlias, pumpkins, watermelons, bananas, salvia miltiorrhiza, etc., without specific limitation here.

[0042] The application methods include but are not limited to spraying, atomizing, dusting, spreading, pouring, coating seeds, etc. It should be noted that when treating plants infested with plant pathogens, the equol or the agricultural fungicide composition can be delivered to the plant or a part of the plant before the plant pathogens appear (i.e., to achieve the requirement of prevention) or after the signs of plant pathogen infestation begin to appear (i.e., to achieve the requirement of control).

[0043] The plant diseases are plant diseases mediated by plant pathogens; the plant pathogens include plant pathogenic fungi and plant pathogenic oomycetes, preferably plant pathogenic oomycetes; further, the plant pathogenic fungi include Fusarium equisetifolia, Fusarium oxysporum, Fusarium solani and Alternaria alternata, and the plant pathogenic oomycetes include Pythium ultimum, Phytophthora nicotianae, Phytophthora sojae, Phytophthora capsici, Pythium aphanidermatum and Pythium solani.

[0044] The present invention is further described below in conjunction with specific examples, which are only for explaining the present invention and do not limit its content. Any simple modification, equivalent changes and modifications made to the implementation methods based on the technical essence of the present invention are within the scope of the technical solution of the present invention.

[0045] Example

[0046] 1. Materials and Methods

[0047] 1.1 Test materials

[0048] Test strains: Phytophthora fusca, Pythium ultimum, Phytophthora sojae, Phytophthora capsici, Pythium aphanidermatum, Pythium solani, Fusarium equiseti, Fusarium oxysporum, Fusarium solani, and Alternaria alternata, all of which are preserved by the Plant Protection Center of the Tobacco Research Institute, Chinese Academy of Agricultural Sciences.

[0049] The experimental tobacco variety: “K326” was provided by the Plant Protection Center of Tobacco Research Institute, Chinese Academy of Agricultural Sciences.

[0050] Test reagents: R-equol / R-Eq original drug, propidium iodide (PI) were purchased from Shanghai Yuanye Biotechnology Co., Ltd., S-equol / S-Eq were purchased from Chengdu Ruifensidan Biotechnology Co., Ltd., V8 vegetable juice was purchased from Zinpro, PBS, agar powder were purchased from Beijing Solebold Technology Co., Ltd. Calcium carbonate, DMSO, tannic acid, crystal violet, Congo red, etc. were purchased from Sinopharm Chemical Reagent Co., Ltd.

[0051] WA medium: 2% water agar medium.

[0052] Preparation of 10% V8 culture medium: Take 100mL V8 vegetable juice, add 1g calcium carbonate and mix and dissolve, filter through four layers of gauze, add 15g agar powder to the filtrate and make up to 1000mL with ultrapure water to prepare a solid culture medium; after filtration, directly add ultrapure water to the filtrate to make up to 1000mL to prepare a liquid culture medium; sterilize at 121℃ for 20min and set aside.

[0053] Drug preparation: 98% of R- / S-Eq original drug was prepared into 100 mg / mL stock solution with DMSO and prepared immediately before use.

[0054] 1.2 Test methods

[0055] 1.2.1 Growth inhibition of R- / S-Eq on oomycetes and fungi

[0056] (1) Preparation of antibacterial agent: Equol was added into DMSO and completely dissolved to obtain antibacterial solution;

[0057] (2) Preparation of V8 medium: V8 vegetable juice (USA) was filtered through four layers of gauze. About 100 mL of the filtrate was taken, 1 g of calcium carbonate was added thereto and mixed and dissolved, 15 g of agar powder was added, and the volume was made up to 1000 mL with ultrapure water. The mixture was sterilized at 121°C for 20 min, cooled to about 50°C, and a medium plate was prepared to obtain a V8 solid medium plate.

[0058] (3) Preparation of antibacterial plates: A certain amount of equol was added to 10% solid V8 medium to prepare a drug-containing medium with a final equol concentration of 100 mg / L. At the same time, a medium plate containing 0.25% (v:v) DMSO was used as a blank control. Each treatment was repeated 3 times to determine the indoor inhibitory activity of R- / S-Eq against oomycetes and fungi.

[0059] (4) Preparation of pathogenic oomycete plates: Place cryopreserved oomycete pieces on V8 solid culture medium plates and culture at 28°C for 7 days. Then place the activated oomycete cakes on the culture medium and culture them in a 28°C incubator in the dark.

[0060] (5) In vitro antibacterial: The growth rate method was used to punch bacterial cakes on each pathogen plate in step (4) using a high-pressure sterilized puncher (d = 0.8 cm). To ensure consistent growth conditions, the center of the mycelium of the strain was used as the origin when punching bacterial cakes. Bacterial cakes were punched with the same radius and then moved to the center of the antibacterial plate in step (3). The moving process was ensured to be sterile.

[0061] (6) Cultivation: The culture dish was placed in an incubator at 28°C for cultivation. The growth of mycelium was observed and measured 7 days after treatment. Photos were taken and the diameter data were measured using the cross method.

[0062] (7) Calculation of inhibition rate: Oomycete hyphae growth inhibition rate (%) = (control colony diameter - treated colony diameter) / control colony diameter × 100%

[0063] 1.2.2 Indoor toxicity of different concentrations of R- / S-Eq to Phytophthora nicotianae

[0064] (1) Preparation of antibacterial agent: Equol was added into DMSO and completely dissolved to obtain antibacterial solution;

[0065] (2) Preparation of V8 medium: V8 vegetable juice (USA) was filtered through four layers of gauze. About 100 mL of the filtrate was taken, 1 g of calcium carbonate was added thereto and mixed and dissolved, 15 g of agar powder was added, and the volume was made up to 1000 mL with ultrapure water. The mixture was sterilized at 121°C for 20 min, cooled to about 50°C, and a medium plate was prepared to obtain a V8 solid medium plate.

[0066] (3) Preparation of antibacterial plates: R- / S-Eq stock solution was mixed with V8 medium in proportion to prepare drug-containing medium plates with final concentrations of 200, 100, 50, 25, and 12.5 mg / L. At the same time, a medium plate containing 0.25% (v:v) DMSO was used as a blank control.

[0067] (4) Preparation of pathogenic oomycete plates: Place cryopreserved oomycete pieces on V8 solid culture medium plates and culture at 28°C for 7 days. Then place the activated oomycete cakes on the culture medium and culture them in a 28°C incubator in the dark.

[0068] (5) In vitro antibacterial: The growth rate method was used to punch bacterial cakes on each pathogen plate in step (4) using a high-pressure sterilized puncher (d = 0.8 cm). To ensure consistent growth conditions, the center of the mycelium of the strain was used as the origin when punching bacterial cakes. Bacterial cakes were punched with the same radius and then moved to the center of the antibacterial plate in step (3). The moving process was ensured to be sterile.

[0069] (6) Cultivation: The culture dish was placed in an incubator at 28°C for cultivation. The growth of mycelium was observed and measured 7 days after treatment. Photos were taken and the diameter data were measured using the cross method.

[0070] (7) Calculation of inhibition rate: Oomycete hyphae growth inhibition rate (%) = (control colony diameter - treated colony diameter) / control colony diameter × 100%.

[0071] 1.2.3 Effects of R-Eq on sporangium formation and zoospore germination of Phytophthora nicotianae

[0072] (1) Preparation of V8 liquid culture medium: V8 vegetable juice (USA) was filtered through four layers of gauze. About 100 mL of the filtrate was taken, 1 g of calcium carbonate was added thereto and mixed and dissolved, and the volume was made up to 1000 mL with ultrapure water. The mixture was sterilized at 121°C for 20 min and cooled to about 50°C to obtain V8 liquid culture medium.

[0073] (2) Inducing mycelium formation: After the oomycetes were transferred to V8 medium and cultured continuously at 28°C in the dark for 3 days, a fungus cake was punched out at the edge of the colony with a hole puncher (d = 0.8 cm) and placed in a sterile, clean culture dish. Eight fungus cakes were placed in each dish and V8 liquid culture medium was added. Three culture dishes were grouped into a group, for a total of 3 groups, and cultured in a dark environment at 28°C for 48 h.

[0074] (3) Inducing sporangium formation: After mycelium is formed, remove the V8 medium and rinse with sterile tap water. Take 30 mL of sterile tap water and add the prepared R-Eq mother solution in proportion. Mix well and add to the culture dish from which the V8 has been removed to prepare a final concentration of 40 mg / L (EC 50 ) and 80mg / L (2×EC 50 ) aqueous solution; the control group was added with 0.25% (v:v) DMSO. Under continuous illumination at 28°C fluorescent lamp, sterile tap water was replaced every 12 hours. After 5 days, sporangium formation could be observed under a microscope and counted. Sporangium formation inhibition rate = (control sporangium number - treatment sporangium number) / control sporangium number × 100%.

[0075] (4) Induce zoospores to release zoospores: Repeat the above steps, but do not add R-Eq. After a large number of sporangia germinate, place the culture dish in a 4°C refrigerator for 30 minutes, and then place it at room temperature for a period of time. A large number of zoospores can be observed to be released. Collect the zoospores in a centrifuge tube, count the zoospores, and calculate the number of zoospores per milliliter of suspension. Observe under a microscope and control the concentration of the zoospore suspension to 1×10 4 Pieces / mL.

[0076] (5) Determination of the effect of R-Eq on the germination of zoospores of Phytophthora nicotianae: The R-Eq mother solution was mixed with WA medium (0.1% V8 liquid medium was added to WA medium) in proportion to prepare a final concentration of 4080 mg / L (EC 50 ) and 80mg / L (2×EC 50) drug-containing medium plate; 0.25% (v:v) DMSO was added to the blank control group. 100 μL of the zoospore suspension was drawn onto the WA drug-containing medium plate (Ф=90mm) and evenly spread so that each plate contained about 1000 zoospores. Cultured at 28℃ in the dark, the zoospore germination was observed under a microscope after 48h, 100 zoospores were randomly counted for each treatment, and the zoospore germination rate was calculated. The experiment was repeated twice.

[0077] 1.2.4 Biological toxicity test of R / S-Eq on zebrafish

[0078] Zebrafish (Danio rerio) were obtained from a local aquarium (Qingdao, China). The length and weight of zebrafish were 3.00 ± 0.02 cm and 0.35 ± 0.02 g, respectively. Zebrafish were pre-cultured under experimental conditions for 2 weeks.

[0079] 2. Results and Analysis

[0080] 2.1 Growth inhibition of R- / S-Eq on oomycetes and fungi

[0081] Table 1 Inhibition rate of R- / S-Eq against different plant pathogens (100 mg / L)

[0082]

[0083] like Figure 1 As shown in Table 1, R- / S-Eq had the highest antibacterial activity against Pythium solani, followed by Pythium ultimum. At a concentration of 100 mg / L, R- / S-Eq exhibited strong anti-oomycete activity and weak antifungal activity, indicating that R- / S-Eq had specific activity against oomycetes.

[0084] 2.2 Indoor toxicity of different concentrations of R- / S-Eq to Phytophthora nicotianae

[0085] Table 2 Effects of different concentrations of R- / S-Eq on the mycelial growth of tobacco phytophthora

[0086]

[0087] The results of indoor toxicity test of R- / S-Eq against tobacco phytophthora Figure 2 Table 2) shows that the inhibitory effect on mycelium increases with the increase of R- / S-Eq concentration. At 100 mg / L, the inhibition rates of R- / S-Eq on tobacco phytophthora mycelium reached 74.82% and 76.69%, respectively. 50 They were 40.21 mg / L and 39.53 mg / L respectively. And under the same concentration of Eq treatment, there was no significant difference in the inhibition rate of the two against tobacco phytophthora.

[0088] 2.3 Effects of R-Eq on sporangium formation and zoospore germination of Phytophthora nicotianae

[0089] Table 3 Inhibition rate of R-Eq on the formation of sporangium and zoospore germination of tobacco phytophthora

[0090]

[0091] Depend on Figure 3 As shown in Table 3, the germination of sporangium of Phytophthora tobacco was sensitive to R-Eq, which had a good inhibitory effect on both sporangium and zoospores. With the increase of R-Eq concentration, the number of sporangium decreased significantly, zoospores germinated later, and the germination rate was low.

[0092] 2.4 Biological toxicity test of R / S-Eq on zebrafish

[0093] The test water was collected from the Zhangcun River buffer zone in Qingdao (3613′34″N, 120°45′51″E; Shandong, China). The samples were collected within 10 m from the center of the river using a five-point sampling method. The physicochemical parameters of the test water were dissolved oxygen 7.01 mg / L, total nitrogen content 0.826 mg / L, total phosphorus content 0.168 mg / L, biochemical oxygen demand 3.91 mg / L, and pH 7.46.

[0094] Use test water to prepare 1.5L of test solution in a 3L glass beaker, and make the R / S-Eq concentrations 10mg / L, 5mg / L, 2.5mg / L, 2mg / L, and 1mg / L respectively; add the same volume of solvent to the control group, and repeat 3 times for each treatment. Put 10 fish in each exposure group, and place all glass beakers in a laboratory at 23±2℃ and relative humidity of 85±2%. Observe and record the number of zebrafish deaths 96 hours after release, and calculate the median lethal concentration at 96h. The results are as follows Figure 4 As shown, the median lethal concentrations of R / S-Eq at 96 h were 2.000 mg / L and 2.477 mg / L, respectively, indicating that equol has low toxicity to non-target organisms such as zebrafish and high safety.

[0095] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims

1. Use of equol in any one or more of the following: (a) inhibiting plant pathogens or preparing plant pathogen inhibitors; (b) Suppressing plant diseases or preparing plant disease suppressants.

2. The application as claimed in claim 1, characterized in that The equol is its pure product, solvate or isomer (including R-equol or S-equol).

3. The application as claimed in claim 1, characterized in that In the above (a), the plant pathogenic bacteria include plant pathogenic fungi and plant pathogenic oomycetes, preferably plant pathogenic oomycetes; equol has specific inhibitory activity against plant pathogenic oomycetes, and has obvious inhibitory effects on the growth of pathogenic oomycetes, the formation of sporangia of pathogenic oomycetes and the production of zoospores.

4. The application as claimed in claim 1, characterized in that The plant pathogenic fungi include Fusarium equisetifolia, Fusarium oxysporum, Fusarium solani and Alternaria alternata, and the plant pathogenic oomycetes include Pythium ultimum, Phytophthora nicotianae, Phytophthora sojae, Phytophthora capsici, Pythium aphanidermatum and Pythium solani.

5. The application as claimed in claim 1, characterized in that In (b), the plant diseases are plant diseases mediated by the plant pathogens in (a), including plant black shank disease, phytophthora blight, wilt, root rot, and brown spot disease.

6. An agricultural fungicide composition, characterized in that: The invention at least comprises equol and auxiliary materials.

7. The agricultural fungicide composition according to claim 6, characterized in that: The equol is a pure product, a solvate or an isomer thereof (including R-equol or S-equol); The auxiliary materials include one or more of a dispersant, a wetting agent, a disintegrant, a binder, a defoamer, an antifreeze agent, a thickener, a filler and a solvent.

8. A method for preventing and controlling plant diseases, characterized in that: The method comprises applying equol or the agricultural fungicide composition of claim 6 or 7 to the plant.

9. The method according to claim 8, characterized in that The plants include trees, fruit trees, vegetables, food crops and cash crops, and further include soybean, corn, wheat, pepper, cotton, tomato, beet, sweet potato, tobacco, eggplant, strawberry, apple, citrus, chrysanthemum, dahlia, pumpkin, watermelon, banana and salvia miltiorrhiza.

10. The method according to claim 8, characterized in that The plant diseases are plant diseases mediated by plant pathogens; the plant pathogens include plant pathogenic fungi and plant pathogenic oomycetes, preferably plant pathogenic oomycetes; further, the plant pathogenic fungi include Fusarium equisetifolia, Fusarium oxysporum, Fusarium solani and Alternaria alternata, and the plant pathogenic oomycetes include Pythium ultimum, Phytophthora nicotianae, Phytophthora sojae, Phytophthora capsici, Pythium aphanidermatum and Pythium solani.

Citation Information

Patent Citations

  • New medical application of equol in prevention and treatment of pathogenic fungus and bacterial infection

    CN116077488A

Cited By

  • Preparation method and application of antifungal illinomycin

    CN120158372A